Century Therapeutics (IPSC) Net Margin (2022 - 2025)
Century Therapeutics' (IPSC) quarterly Net Margin came in at 70.13% in Q1 2025, up 335224.0% year-on-year from N/an in Q1 2024, and up 108.2% on a QoQ basis from 854.85% in Q4 2024.
Century Therapeutics (IPSC) Net Margin (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Net Margin data on file, last reported at 70.13% in Q1 2025.
- On a quarterly basis, Net Margin rose 335224.0% year-over-year to 70.13% in Q1 2025; TTM through Dec 2025 was 0.05%, a 191458.0% increase from a year earlier, with the FY2025 full-year figure at 1.9%, up 191669.0% from the prior year.
- Net Margin for Q1 2025 stood at 70.13%, up from 854.85% in the prior quarter.
- Over the last five years, Net Margin for IPSC reached as high as 70.13% in Q1 2025 and fell as low as 33627.27% in Q2 2023.
- Historically, Net Margin has averaged 7503.45% across 4 years, with a median of 3545.65% in 2022.
- Across the five-year window, Net Margin plunged 3140750 bps in 2023 and surged 2957967 bps in 2024, its largest moves.
- Year by year, Net Margin stood at 6081.0% in 2022, then plunged by 142 bps to 14700.75% in 2023, then jumped by 94 bps to 854.85% in 2024, then soared by 108 bps to 70.13% in 2025.
- Per Business Quant data, the three most recent Net Margin figures were 70.13% in Q1 2025, 854.85% in Q4 2024, and 3947.66% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 70.13% |
| Dec 31, 2024 | -854.85% |
| Sep 30, 2024 | -3,947.66% |
| Jun 30, 2024 | -4,047.60% |
| Mar 31, 2024 | -3,282.11% |
| Dec 31, 2023 | -14,700.75% |
| Sep 30, 2023 | -22,108.11% |
| Jun 30, 2023 | -33,627.27% |
| Mar 31, 2023 | -1,817.67% |
| Dec 31, 2022 | -6,081.00% |
| Sep 30, 2022 | -1,382.60% |
| Jun 30, 2022 | -2,219.77% |
| Mar 31, 2022 | -3,545.65% |